According to the US Centers for Disease Control and Prevention, prostate cancer is the second leading cause of cancer death among men. One of the standard approaches for the diagnosis and treatment of ...

A prostate biopsy checks for prostate cancer by extracting tissue samples. A transperineal biopsy has a lower infection risk than a transrectal biopsy. Biopsy results are usually ready within about ...

The MRI-based prostate biopsy risk stratification tools with the greatest accuracy were the RPCRC-MRI and PLUM models Among MRI-based risk calculators for prostate biopsy, 2 models provide more ...

Screening for prostate cancer is burdened by a high rate of overdiagnosis. The most appropriate algorithm for population-based screening is unknown. We invited 37,887 men who were 50 to 60 years of ...

Omitting systematic biopsy in men with elevated prostate-specific antigen (PSA) levels and negative MRI results, and performing only targeted biopsy of MRI-positive lesions, eliminated more than half ...

Data on the efficacy and safety of screening for prostate cancer with magnetic resonance imaging (MRI) are needed from studies of follow-up screening. In a population-based trial that started in 2015, ...

Omitting systematic biopsy may reduce adverse events and complications. Urologists may be able to skip systematic biopsy (SB) and perform targeted prostate biopsy (TB) alone in men with PI-RADS 5 ...

In patients with a high suspicion of prostate cancer as determined by molecular imaging, avoiding biopsy prior to radical prostatectomy appeared to be feasible, and "might represent a valid option in ...

As part of the “Speaking Out” series, a radiation oncologist discusses the benefits of MRI-guided stereotactic body radiation therapy. Dr. Matthew Solhjem, a radiation oncologist with Providence ...